Search Results - Jing-Quan Wang

Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment by Houwen Zou, Yuqi Yang, Huiqiang Dai, Yunchuang Xiong, Jing-Quan Wang, Lusheng Lin, Zhe-Sheng Chen

Connect to this object online.

Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19 by Wei-Xi Shen, Wei-Xi Shen, Rong-Cheng Luo, Rong-Cheng Luo, Jing-Quan Wang, Zhe-Sheng Chen

Connect to this object online.

The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells by Hai-Ling Gao, Qingbin Cui, Jing-Quan Wang, Charles R. Ashby, Yanchun Chen, Zhi-Xin Shen, Zhe-Sheng Chen

Connect to this object online.

MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter: In vitro and in vivo study by Zhuo-Xun Wu, Qiu-Xu Teng, Yuqi Yang, Nikita Acharekar, Jing-Quan Wang, Min He, Sabesan Yoganathan, Jun Lin, Jian Wang, Zhe-Sheng Chen

Connect to this object online.

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells by Zhuo-Xun Wu, Yuqi Yang, Jing-Quan Wang, Wen-Min Zhou, Junyu Chen, Yi-Ge Fu, Ketankumar Patel, Zhe-Sheng Chen, Jian-Ye Zhang

Connect to this object online.

OTS964, a TOPK Inhibitor, Is Susceptible to ABCG2-Mediated Drug Resistance by Yuqi Yang, Zhuo-Xun Wu, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar, Zhe-Sheng Chen, Dong-Hua Yang

Connect to this object online.

Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR by Yuval Bin Kanner, Qiu-Xu Teng, Assaf Ganoth, Assaf Ganoth, Dan Peer, Dan Peer, Dan Peer, Dan Peer, Jing-Quan Wang, Zhe-Sheng Chen, Yossi Tsfadia

Connect to this object online.

The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents by Shao-Jia Qiang, Yu-Qi Shi, Tong-Yu Wu, Jing-Quan Wang, Xue-Lian Chen, Jie Su, Xin-Ping Chen, Jia-Zhong Li, Zhe-Sheng Chen

Connect to this object online.

Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cells by Xuan-Yu Chen, Xuan-Yu Chen, Zhuo-Xun Wu, Jing-Quan Wang, Qiu-Xu Teng, Hailin Tang, Qianwen Liu, Zhe-Sheng Chen, Zhe-Sheng Chen, Wenkuan Chen

Connect to this object online.

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters by Ning Ji, Ning Ji, Yuqi Yang, Chao-Yun Cai, Zi-Ning Lei, Jing-Quan Wang, Pranav Gupta, Qiu-Xu Teng, Zhe-Sheng Chen, Dexin Kong, Dong-Hua Yang

Connect to this object online.

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance by Xiaofang Luo, Qiu-Xu Teng, Jin-Yun Dong, Dong-Hua Yang, Meifeng Wang, Wubliker Dessie, Jiang-Jiang Qin, Zi-Ning Lei, Jing-Quan Wang, Zuodong Qin, Zhe-Sheng Chen

Connect to this object online.

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells by Lei Zhang, Lei Zhang, Lei Zhang, Biwei Ye, Biwei Ye, Yunfeng Lin, Yunfeng Lin, Yi-Dong Li, Jing-Quan Wang, Zhuo Chen, Zhuo Chen, Feng-Feng Ping, Zhe-Sheng Chen

Connect to this object online.

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells by Wei Zhang, Wei Zhang, Ying-Fang Fan, Ying-Fang Fan, Chao-Yun Cai, Jing-Quan Wang, Qiu-Xu Teng, Zi-Ning Lei, Leli Zeng, Leli Zeng, Pranav Gupta, Zhe-Sheng Chen

Connect to this object online.

Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer Cells by Xing-Duo Dong, Meng Zhang, Chao-Yun Cai, Qiu-Xu Teng, Jing-Quan Wang, Yi-Ge Fu, Qingbin Cui, Qingbin Cui, Ketankumar Patel, Dong-Tao Wang, Dong-Tao Wang, Zhe-Sheng Chen

Connect to this object online.